News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
223,289 Results
Type
Article (14274)
Company Profile (29)
Press Release (208986)
Multimedia
Podcasts (9)
Webinars (8)
Section
Business (63149)
Career Advice (927)
Deals (11009)
Drug Delivery (35)
Drug Development (30652)
Employer Resources (85)
FDA (5306)
Job Trends (4879)
News (111399)
Policy (9594)
Tag
2024 BioMidwest Digital (3)
2024 Bio NC Digital (1)
2024 Biotech Bay Standard (5)
2024 Biotech Beach Standard (2)
2024 Genetown Standard (3)
2024 Pharm Country Standard (2)
2025 Lone Star Bio Digital (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (1156)
Academic (1)
Accelerated approval (1)
Adcomms (8)
Allergies (39)
Alliances (16127)
ALS (39)
Alzheimer's disease (482)
Antibody-drug conjugate (ADC) (23)
Approvals (5340)
Artificial intelligence (70)
Autoimmune disease (8)
Automation (4)
Bankruptcy (101)
Best Places to Work (4078)
BIOSECURE Act (8)
Biosimilars (41)
Biotechnology (14)
Bladder cancer (32)
Brain cancer (9)
Breast cancer (103)
Cancer (721)
Cardiovascular disease (64)
Career advice (774)
Career pathing (22)
CAR-T (55)
Cell therapy (134)
Cervical cancer (10)
Clinical research (26098)
Collaboration (196)
Compensation (25)
Complete response letters (1)
COVID-19 (1157)
CRISPR (9)
C-suite (79)
Cystic fibrosis (21)
Data (848)
Denatured (6)
Depression (9)
Diabetes (100)
Diagnostics (1988)
Digital health (5)
Diversity (5)
Diversity, equity & inclusion (29)
Drug discovery (41)
Drug pricing (40)
Drug shortages (16)
Duchenne muscular dystrophy (36)
Earnings (20113)
Editorial (16)
Employer branding (5)
Employer resources (75)
Events (25097)
Executive appointments (255)
FDA (5702)
Featured Employer (11)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (1)
Funding (231)
Gene editing (21)
Generative AI (8)
Gene therapy (97)
GLP-1 (284)
Government (1520)
Grass and pollen (2)
Guidances (10)
Healthcare (6857)
Huntington's disease (6)
IgA nephropathy (9)
Immunology and inflammation (34)
Indications (8)
Infectious disease (1211)
Inflammatory bowel disease (56)
Inflation Reduction Act (4)
Influenza (22)
Intellectual property (20)
Interviews (148)
IPO (4337)
IRA (20)
Job creations (968)
Job search strategy (680)
Kidney cancer (2)
Labor market (11)
Layoffs (108)
Leadership (9)
Legal (1802)
Liver cancer (27)
Lung cancer (105)
Lymphoma (51)
Machine learning (1)
Management (29)
Manufacturing (87)
MASH (34)
Medical device (4124)
Medtech (4126)
Mergers & acquisitions (6830)
Metabolic disorders (231)
Multiple sclerosis (43)
NASH (15)
Neurodegenerative disease (27)
Neuropsychiatric disorders (3)
Neuroscience (678)
NextGen: Class of 2025 (2407)
Non-profit (1812)
Northern California (666)
Now hiring (3)
Obesity (104)
Opinion (65)
Ovarian cancer (19)
Pain (36)
Pancreatic cancer (24)
Parkinson's disease (59)
Partnered (8)
Patents (36)
Patient recruitment (37)
Peanut (23)
People (23200)
Pharmaceutical (12)
Pharmacy benefit managers (9)
Phase I (5967)
Phase II (11255)
Phase III (10465)
Pipeline (400)
Policy (59)
Postmarket research (1231)
Preclinical (2150)
Press Release (31)
Prostate cancer (36)
Psychedelics (10)
Radiopharmaceuticals (78)
Rare diseases (117)
Real estate (1717)
Recruiting (31)
Regulatory (6997)
Reports (19)
Research institute (1006)
Resumes & cover letters (132)
Rett syndrome (1)
RNA editing (1)
RSV (22)
Schizophrenia (25)
Series A (53)
Series B (32)
Service/supplier (5)
Sickle cell disease (12)
Southern California (572)
Special edition (3)
Spinal muscular atrophy (67)
Sponsored (4)
Startups (1329)
Stomach cancer (5)
Supply chain (16)
Tariffs (6)
The Weekly (3)
United States (6038)
Vaccines (297)
Venture capitalists (10)
Weight loss (75)
Women's health (15)
Worklife (10)
Date
Today (23)
Last 7 days (134)
Last 30 days (698)
Last 365 days (10066)
2025 (2853)
2024 (10636)
2023 (12201)
2022 (19989)
2021 (21589)
2020 (19547)
2019 (16563)
2018 (12892)
2017 (11351)
2016 (10827)
2015 (12817)
2014 (9027)
2013 (7004)
2012 (7559)
2011 (8077)
2010 (6905)
Location
Africa (309)
Alabama (13)
Alaska (4)
Arizona (48)
Arkansas (2)
Asia (14372)
Australia (2977)
California (1481)
Canada (561)
China (184)
Colorado (68)
Connecticut (77)
Delaware (54)
Europe (38069)
Florida (186)
Georgia (76)
Idaho (16)
Illinois (171)
India (12)
Indiana (99)
Iowa (4)
Japan (76)
Kansas (32)
Kentucky (7)
Louisiana (5)
Maine (19)
Maryland (243)
Massachusetts (1069)
Michigan (50)
Minnesota (96)
Missouri (18)
Montana (6)
Nebraska (6)
Nevada (24)
New Hampshire (10)
New Jersey (582)
New Mexico (10)
New York (540)
North Carolina (266)
Northern California (666)
Ohio (53)
Oklahoma (4)
Oregon (6)
Pennsylvania (369)
Puerto Rico (6)
Rhode Island (4)
South America (452)
South Carolina (7)
Southern California (572)
Tennessee (23)
Texas (187)
Utah (31)
Virginia (32)
Washington D.C. (21)
Washington State (182)
West Virginia (1)
Wisconsin (11)
223,289 Results for "bionomics consulting group".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Bionomics to Participate in the 2024 Maxim Healthcare Virtual Summit, Presented by Maxim Group LLC
October 15, 2024
·
2 min read
Press Releases
Bionomics to Present at the 2024 CNS Summit
November 8, 2024
·
3 min read
Press Releases
Bionomics to Present at the 2024 American College of Neuropsychopharmacology Annual Meeting
December 4, 2024
·
4 min read
Press Releases
Duchesnay Pharmaceutical Group creates Advisory Board to help guide the Group’s growth and success
April 16, 2025
·
5 min read
Genetown
Bionomics Limited Announces Private Placement of up to $70.0 Million
Bionomics Limited announced it has entered into a securities purchase agreement with an institutional accredited investor to purchase American Depository Shares and accompanying warrants in a three-tranche private placement.
May 31, 2024
·
7 min read
Genetown
Bionomics to Present at the 2024 American Society of Clinical Psychopharmacology Annual Meeting
Bionomics Limited announced that Spyridon “Spyros” Papapetropoulos, M.D., PhD, President and Chief Executive Officer of Bionomics will be giving an oral presentation and presenting two posters about BNC210 as a potential treatment for social anxiety disorder and post-traumatic stress disorder at the 2024 American Society of Clinical Psychopharmacology Annual Meeting taking place May 28 – 31 in Miami Beach, Florida.
May 20, 2024
·
4 min read
Genetown
Bionomics to Present at the 2024 BIO CEO & Investor Conference
Bionomics Limited (Nasdaq: BNOX) (Bionomics or Company) today announced that it will be presenting at the 2024 BIO CEO & Investor Conference taking place February 26-27, 2024 in New York, NY.
February 22, 2024
·
3 min read
Press Releases
Bionomics Limited announces intention to re-domicile to the United States
October 1, 2024
·
9 min read
Press Releases
Rimkus Acquires Human Factors Consulting Services, Incorporated, Enhancing Expertise in Human Factors and Medical Device Consulting
March 6, 2025
·
2 min read
Press Releases
Bionomics Publishes the Positive Results from the Phase 2 ATTUNE Study of BNC210 in Patients with Post-Traumatic Stress Disorder in NEJM Evidence
December 9, 2024
·
5 min read
1 of 22,329
Next
